Concepedia

Joanna Lisztwan

JL

Statistics

Publications

11

Citations

2.2K

H-Index

11

Active since

1998

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Friedrich Miescher Institute

Joanna Lisztwan is an author at Novartis (Switzerland) specializing in molecular oncology, oncology, and medicine.

Publications per year

1998–2014

11

Publications

11

Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL

Peter Staller, Jitka Sulitkova, Joanna Lisztwan et al. · Nature · 2003 · 865 citations · Full text

, , +12

The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity

Joanna Lisztwan, G. Imbert, C Wirbelauer et al. · Genes & Development · 1999 · 380 citations · Full text

, , +15

Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL

Alexander Hergovich, Joanna Lisztwan, Robert E. Barry et al. · Nature Cell Biology · 2002 · 338 citations

, , +12

Association of human CUL‐1 and ubiquitin‐conjugating enzyme CDC34 with the F‐box protein p45SKP2: evidence for evolutionary conservation in the subunit composition of the CDC34–SCF pathway

Joanna Lisztwan · The EMBO Journal · 1998 · 204 citations

, , +13

Comprehensive Mapping of p53 Pathway Alterations Reveals an Apparent Role for Both SNP309 and <i>MDM2</i> Amplification in Sarcomagenesis

Moriko Ito, Louise Barys, Terence O’Reilly et al. · Clinical Cancer Research · 2010 · 112 citations

, , +17

1–5 of 11